How do Premarin Vaginal Cream and Estrace Cream compare side by side?
From the US Premarin Vaginal Cream and Estrace Cream labels. Neither label reports a trial against the other. The four rows above are the short version.
Show all 9 rowsHide table
| Premarin Vaginal Cream | Estrace Cream | |
|---|---|---|
| Estrogen | Conjugated estrogens 0.625 mg per gram1 | Estradiol 0.1 mg per gram2 |
| Approved for | Atrophic vaginitis and kraurosis vulvae; moderate to severe painful sex from menopause1 | Moderate to severe vulvar and vaginal atrophy from menopause2 |
| Schedule | 0.5 to 2 g daily for 21 days then 7 off; for painful sex, 0.5 g twice weekly or 21/71 | 2 to 4 g daily for 1 to 2 weeks, then half; maintenance 1 g one to three times a week2 |
| Applicator | Marked in 0.5 g steps up to 2 g1 | Marked at 1, 2, 3 and 4 g2 |
| Tube | 30 g1 | 42.5 g (1 ½ oz)2 |
| Side-effect rates | 12-week trial: breast pain 4.9% (21/7) vs 0% on placebo; headache 3.5% vs 1.4%1 | None given; reactions listed without percentages2 |
| Endometrium | No hyperplasia or cancer in a 52-week study (155 biopsies)1 | No study reported in the label2 |
| Missed dose | No instruction in the label1 | No instruction in the label2 |
| Boxed warning | WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER and PROBABLE DEMENTIA1 | WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER and PROBABLE DEMENTIA2 |
Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.
What evidence does each label report?
The Premarin Vaginal Cream label reports a 12-week placebo-controlled study of two schedules, 0.5 g daily for 21 days then 7 off, and 0.5 g twice weekly. Superficial vaginal cells rose 28% and 26% vs 3% and 1% on placebo, and vaginal pH fell 1.62 and 1.57 vs 0.36 and 0.26. A 52-week study found no endometrial hyperplasia or cancer.1
The Estrace Cream label is an older format with no clinical studies section and no side-effect percentages. It lists reactions reported with estrogen therapy in general.2
What do they share?
Both labels say some estrogen is absorbed into the body, so the warnings for estrogen apply, and both carry the same boxed warning title. Both discuss adding a progestin for a woman with a uterus, use the lowest dose for the shortest time, and talk about the need for treatment regularly, for example every 3 to 6 months.12
Which, if either, fits is for your prescriber. More detail: Premarin Vaginal Cream side effects, Estrace Cream side effects, the Premarin Vaginal Cream and Estrace Cream dosing schedules and Estrace Cream vs Vagifem: how do the two vaginal estradiol products differ?.
Frequently asked questions
Do Premarin Vaginal Cream and Estrace Cream contain the same estrogen?
How often is each used?
What if I miss a dose?
Can Dose Track remind me to use it?
Yes. You can log each dose and set reminders for set days or on and off weeks.
Related comparisons
- Estrace Cream vs Vagifem: how do the two vaginal estradiol products differ?Estradiol cream vs 10 mcg estradiol insert
- Imvexxy vs Estrace Cream: how do the estradiol insert and cream differ?Small estradiol insert vs cream measured by applicator
- Estring vs Femring: how do the two estrogen vaginal rings differ?Low-dose local ring vs higher-dose ring
- Free reconstitution calculatorVial strength and water to syringe units
See also
- Estradiol (oral tablets): tablet strengths, label uses and warnings
- Activella side effects
- Activella dosing schedule
- Premarin vs estradiol tablets: how do the two oral estrogens differ?
- Climara Pro vs Prempro: how does a combination patch compare with a combination pill?
Track it in Dose Track: GLP-1 tracker, TRT tracker or peptide tracker.
Sources
- Premarin (conjugated estrogens) vaginal cream prescribing information and Patient Information, boxed warning and sections 1, 2, 3, 5, 6, 14 and 16. DailyMed, version of June 2, 2025.
- Estrace (estradiol vaginal cream USP 0.01%) prescribing information and Patient Information: Boxed Warning, Description, Indications and Usage, Warnings, Adverse Reactions, Dosage and Administration, How Supplied. DailyMed, version of November 5, 2024.
All compound comparisons · All compound guides · Peptide tracking in Dose Track